ACA Champion Brooks-LaSure Confirmed As CMS Chief On 55-44 Senate Vote

Chiquita Brooks-LaSure, a key player in the passing and implementation of the Affordable Care Act, was confirmed on 25 May as the next administrator of the US Centers for Medicare and Medicaid Services. At least one industry group is already nudging her to put the Medicare Coverage of Innovative Technology (MCIT) rule for breakthrough devices into effect.

Chiquita Brooks-LaSure appears during an April Senate hearing for her nomination to be CMS administrator.
Brooks-LaSure at an April Senate hearing for her nomination to be CMS administrator • Source: Alamy

The US Senate on 25 May confirmed Chiquita Brooks-LaSure as the next administrator of the Centers for Medicare and Medicaid Services (CMS).

The vote was 55-44, with five Republicans joining all Democrats in Brooks-LaSure’s confirmation. She replaces acting CMS chief Liz Richter.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Leadership

Cardiosense Advances Noninvasive Heart Monitoring With Final Validation Study

 
• By 

Cardiosense has launched a nationwide clinical study, SEISMIC-HF II, to validate its non-invasive, AI-powered technology for monitoring heart failure. The data will be used to file for US regulatory clearance of the Cardiosense heart failure monitoring platform.

Handheld Diagnostics: A Resurging Category That is Here to Stay

 

Handheld diagnostics are more powerful, accessible and clinically relevant than ever. Medtech Insight spoke to companies behind such technologies to learn how they work and discuss their commercial models.

Execs On The Move: 12-23 May 2025

 
• By 

An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.

German Bionic Launches ‘Strongest Exoskeleton To Date’

 

German Bionic’s new exoskeleton Exia helps healthcare practitioners, nurses, and other caregivers to lift and move patients by supporting muscle movement and reducing the risk of injury.

More from Medtech Insight

Get Ready For International Harmonization Before Approaching QMSR Deadline, Says Regulatory Expert

 

During MD&M East last week, regulatory consultant Darren Reeves reminded device manufacturers that the time to get ready to comply with the new Quality Management System Regulation is now.

Handheld Diagnostics: A Resurging Category That is Here to Stay

 

Handheld diagnostics are more powerful, accessible and clinically relevant than ever. Medtech Insight spoke to companies behind such technologies to learn how they work and discuss their commercial models.

Execs On The Move: 12-23 May 2025

 
• By 

An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.